Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,510.00
-140.00 (-1.62%)
At close: Apr 29, 2026

Kwang Dong Pharmaceutical Revenue

In the year 2025, Kwang Dong Pharmaceutical had annual revenue of 1.66T KRW with 1.15% growth. Kwang Dong Pharmaceutical had revenue of 412.10B in the quarter ending December 31, 2025, with 5.44% growth.

Revenue
1,659.51B
Revenue Growth
+1.15%
P/S Ratio
0.19
Revenue / Employee
1.63B
Employees
1,021
Market Cap
311.61B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251,659.51B18.79B1.15%
Dec 31, 20241,640.72B126.26B8.34%
Dec 31, 20231,514.45B82.91B5.79%
Dec 31, 20221,431.55B93.36B6.98%
Dec 31, 20211,338.18B94.41B7.59%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sajodaerim 3,499.81B
Sajo Industries Company 706.21B
EASY HOLDINGS 3,388.90B
Maeil Dairies 1,843.54B
Daesang Holdings 5,628.80B
Daehan Flour Mills Co.,Ltd 1,375.20B
Namyang Dairy Products 914.15B
Samlip 3,370.48B
Revenue Rankings